PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF ORAL 4-DEMETHOXYDAUNORUBICIN IN ADVANCED NON-PRETREATED SMALL-CELL LUNG-CANCER

被引：0
|
作者：
MILROY, R [1 ]
CUMMINGS, J [1 ]
KAYE, SB [1 ]
BANHAM, SW [1 ]
机构：
[1] UNIV GLASGOW,DEPT MED ONCOL,GLASGOW G12 8QQ,SCOTLAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1987年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF ORAL 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    KRIS, MG
    GRALLA, RJ
    KELSEN, DP
    CASPER, ES
    BURKE, MT
    FIORE, JJ
    CIBAS, IR
    HEELAN, RT
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05): : 377 - 379
  • [2] PHASE-II TRIAL OF 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    JOSS, RA
    OBRECHT, JP
    ALBERTO, P
    SIEGENTHALER, P
    VANHELVOIRT, A
    CAVALLI, F
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 563 - 564
  • [3] ORAL 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN BRONCHOGENIC LUNG-CANCER - PHASE-II TRIAL
    HOCHSTER, HS
    GREEN, MD
    BLUM, RH
    WERNZ, JC
    SPEYER, JL
    MUGGIA, FM
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (03) : 275 - 278
  • [4] PHASE-II STUDY OF 4-DEMETHOXYDAUNORUBICIN IN PREVIOUSLY UNTREATED EXTENSIVE DISEASE NON-SMALL-CELL LUNG-CANCER
    UMSAWASDI, T
    FELDER, TB
    JEFFRIES, D
    NEWMAN, RA
    INVESTIGATIONAL NEW DRUGS, 1990, 8 : S73 - S78
  • [5] A PHASE-II TRIAL OF ORAL 4'-DEMETHOXYDAUNORUBICIN (DMDR) IN INOPERABLE NON SMALL CELL LUNG-CANCER
    PRESGRAVE, P
    WOODS, R
    KEFFORD, R
    BELL, D
    RAGHAVAN, D
    LEVI, J
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (03) : 219 - 221
  • [6] A PHASE-II STUDY OF ORAL WEEKLY 4-DEMETHOXYDAUNORUBICIN IN ADVANCED BREAST-CANCER
    SMITH, DB
    HOWELL, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (04): : 391 - 394
  • [7] A PHASE-II STUDY OF ORAL IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED BREAST-CANCER
    STUART, NSA
    CULLEN, MH
    PRIESTMAN, TJ
    BLACKLEDGE, GRP
    TYRRELL, CJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (04) : 351 - 354
  • [8] A PHASE-II STUDY OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED MYELOMA
    CHISESI, T
    CAPNIST, G
    DEDOMINICIS, E
    DINI, E
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 681 - 684
  • [9] A PHASE-II STUDY WITH ORAL 4-DEMETHOXYDAUNORUBICIN IN METASTATIC BREAST-CANCER
    PRONZATO, P
    LIONETTO, R
    GULISANO, M
    BERTELLI, G
    CONTE, PF
    SERTOLI, MR
    ROSSO, R
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 172 - 172
  • [10] PHASE-II TRIAL OF ORAL IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED BREAST-CANCER
    WANDER, HE
    MEYER, D
    SCHUFFWERNER, P
    NAGEL, GA
    ONKOLOGIE, 1986, 9 (04): : 236 - 238
12345